Thus, a therapeutic strategy focusing on suppression of postprandial hyperglycemia and improvement of insulin signaling could be a valuable treatment strategy for not only the treatment of diabetic patients, but also individuals with impaired glucose tolerance. The gene discussed is INS; the disease is Hyperglycemia.